As shown above in Fig 6A, peptide plus CpG vaccination was rendered therapeutically effective if it was continued into the tumor-bearing state; the absence of MUC1-sensitized T-cells, or a lack of concurrent tumor and vaccine, negated therapy. Here, MUC1 is linked to neoplasm.